Lonza | LONN - Loan Capital



Lonza reported CHF4.24B in Loan Capital for its fiscal semester ending in December of 2024.


Loan Capital Change Date
Akzo Nobel EUR 3.66B 514M Jun/2025
Alcon AG USD 4.66B 68M Jun/2025
Almirall EUR 365.88M 24.38M Jun/2025
AstraZeneca USD 25.99B 1.9B Jun/2025
BASF EUR 18.96B 85M Jun/2025
Bayer EUR 31.71B 3.31B Jun/2025
Beiersdorf EUR 132M 20M Jun/2025
Covestro EUR 2.11B 153M Jun/2025
Demant DKK 15.27B 677M Jun/2025
Fresenius EUR 9.31B 2.08B Jun/2025
Fresenius Medical Care EUR 6.33B 3.18B Jun/2025
Geberit 1.09B 290M Dec/2024
Genmab DKK 132M 3M Jun/2025
Givaudan CHF 4.29B 175M Jun/2024
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
GN Store Nord DKK 9.04B 279M Jun/2025
Hikma Pharmaceutical USD 607M 454M Dec/2024
Johnson Matthey GBP 1.34B 214M Mar/2025
Merck EUR 6.3B 665M Jun/2025
Novartis USD 24.06B 2.4B Jun/2025
Philips EUR 7.18B 126M Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
Sanofi 13.2B 211M Jun/2025
Sika AG CHF 5.09B 283M Dec/2024
Smith & Nephew USD 3.3B 39M Jun/2025
Solvay EUR 2.05B 44M Jun/2025
UCB EUR 2.96B 21M Dec/2024